Clinical Trial Update: A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis

View source ↗

Summary

This clinical trial update reports the completed study of oral upadacitinib in adults with moderate-to-severe rheumatoid arthritis, examining treatment patterns…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis (RA) | Status: COMPLETED